Reliable Brokers
Online Investing
Alerts & Analysis
Easy Trading

New immune system discovery may potentially cure cancer

The researchers believe that this medical discovery might be able to tackle all cancers

Update : 21 Jan 2020, 05:08 PM

Scientists have discovered a new part of the immune system of humans that could be utilized to cure cancer.

This major breakthrough in the treatment of cancer came from a research team of Cardiff University, who also published their findings in Nature Immunology.

The researchers believe that this medical discovery might be able tackle all cancers including prostate, breast, lung cancers reports BBC.

Although the method is yet to be tested on patients, the researchers are hopeful of the results.

Being a natural defence against infection for the human body, the immune system is also known to attack cancerous cells.

Therefore, scientists have been searching for an alternative or a previously undiscovered ways of how the immune system attacks these cancerous cells, and found a T-cell inside people’s blood that examines the body looking for threats that must be eradicated.

T-cells have "receptors" on their surface that allow them to "see" at a chemical level, reports BBC.

Moreover, during lab tests, the research team found that these newly discovered T-cell have the potential to attack a wide range of cancerous cells, while sparing normal tissues from the decimation.

Speaking to the BBC, researcher Prof Andrew Sewell said: “There is a chance here to treat every patient,” adding: "Previously nobody believed this could be possible.”

"It raises the prospect of a 'one-size-fits-all' cancer treatment, a single type of T-cell that could be capable of destroying many different types of cancers across the population," he furthered.

However, the team is still researching the method on how the T-cells actually carry out the attack.

They believe T-cell receptors communiate with a particular molecule on the surace of every cell in the human body, called MR1.

"We are the first to describe a T-cell that finds MR1 in cancer cells - that hasn't been done before, this is the first of its kind," research fellow Garry Dolton told the BBC.

Although T-cell cancer therapies already exist, the most widely known treatment being CAR-T which is a living drug made by genetically engineering a patient's T-cells to hunt for cancerous cells and destroy them, it used to be very specific and worked on only a limited type of cancers.

However, with this breakthrough, researchers believe that the T-cell treatment is capable of treating cancers universally, reports BBC.

The treatment would begin with collecting a patient’s blood sample, and then genetically modify the T-cells and after extracting them from the blood cells so that they can find the cancer cells.

Then, the reprogrammed cells will be multiplied in the labs and injected into the patient’s body using the same process as CAR-T therapies.

Many experts have lauded the "great potential" of these findings but believe that it is too early to tell whether it would actually be able heal all types of cancers.

Lucia Mori and Gennaro De Libero, from University of Basel in Switzerland, said: "We are very excited about the immunological functions of this new T-cell population and the potential use of their TCRs in tumour cell therapy.”

Daniel Davis, a professor of immunology at the University of Manchester, said: "At the moment, this is very basic research and not close to actual medicines for patients.

"There is no question that it's a very exciting discovery, both for advancing our basic knowledge about the immune system and for the possibility of future new medicines."

Top Brokers